Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Psychotherapy

Psychotherapy

Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Group Therapy

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

SD-OCT-histopathologic correlation in Schnabel's cavernous optic nerve atrophy.

Eye (London, England)·2025

Same author

Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression.

Nature communications·2024

Same author

Prosthetic Visual Acuity with the PRIMA System in Patients with Atrophic Age-related Macular Degeneration at 4 years follow-up.

medRxiv : the preprint server for health sciences·2023

Same author

[Differential diagnosis of eyelid tumors in children: subepidermal calcified nodule].

Die Ophthalmologie·2023

Same author

[Retinal optical coherence tomography biomarkers in dementia].

Die Ophthalmologie·2023

Same author

[Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD].

Die Ophthalmologie·2022

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

[Therapy approaches for geographic atrophy].

S Schmitz-Valckenberg¹, A Mössner, M Fleckenstein

¹Universitäts-Augenklinik Bonn, Ernst-Abbe-Strasse 2, Bonn, Deutschland. steffen.schmitz-valckenberg@ukb.uni-bonn.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft

|November 20, 2010

Summary

This summary is machine-generated.

Geographic atrophy, the advanced stage of dry age-related macular degeneration (AMD), presents a significant challenge. Current research focuses on pharmacologic treatments targeting retinal toxins, inflammation, oxidative stress, and neuroprotection, alongside visual aids for patients.

Related Experiment Videos

Last Updated: Jun 6, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Area of Science:

Ophthalmology
Retinal Diseases
Age-Related Macular Degeneration (AMD)

Context:

Geographic atrophy (GA) represents the late, dry stage of AMD.
GA is a significant challenge following breakthroughs in treating neovascular AMD.
Interventional clinical trials are actively investigating new treatments for GA.

Purpose:

To explore emerging pharmacologic interventions for geographic atrophy.
To highlight the ongoing research into various therapeutic targets for dry AMD.
To emphasize the continued need for visual aids and rehabilitation in advanced GA.

Summary:

Pharmacologic approaches targeting retinal toxins, inflammation, complement inhibition, neuroprotection, and oxidative stress are under investigation.
These interventions are being evaluated in clinical trials for efficacy and safety.
Despite ongoing research, visual aids and rehabilitative measures are crucial for patients with advanced dry AMD.

Impact:

Advances in understanding and treating geographic atrophy are critical for preserving vision in aging populations.
Successful interventions could significantly improve the quality of life for individuals with advanced dry AMD.
This research paves the way for future therapeutic strategies against degenerative retinal diseases.